Completed PHASE2 NCT01462292

A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)

An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy

Sponsor: GlaxoSmithKline

Conditions Muscular Dystrophies

Interventions GSK2402968 3mg/kg/week GSK2402968 6 mg/kg/week Placebo to match GSK2402968 3 mg/kg/week Placebo to match GSK2402968 6 mg/kg/week

Updated 10 times since 2017 Last updated: Sep 13, 2017 Started: Oct 26, 2011 Primary completion: May 21, 2013 Completion: Nov 4, 2013

Listed as NCT01462292, this PHASE2 trial focuses on Muscular Dystrophies and remains completed. Sponsored by GlaxoSmithKline, it has been updated 10 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2

▶ Show 5 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Oct 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Oct 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baltimore, United States , Cincinnati, United States , Columbus, United States , Dallas, United States , Durham, United States , Gulf Breeze, United States , Iowa City, United States , Kansas City, United States , Minneapolis, United States , New York, United States and 4 more locations